Published in Lupus on January 01, 2007
Differentiating malignant hypertension-induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura. Ther Adv Hematol (2015) 0.76
Pure lupus podocytopathy first presenting as thrombotic thrombocytopenic purpura-like syndrome. Clin Rheumatol (2015) 0.75
Human BSE. Nature (1997) 11.79
Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease. QJM (2002) 3.09
Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting. Lancet (1976) 1.89
Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion. Bone Marrow Transplant (2001) 1.54
Correlation of 24-hour urinary protein quantification with spot urine protein:creatinine ratio in lupus nephritis. Lupus (2012) 1.42
Sulphamethoxazole-trimethoprim in the treatment of limited paranasal Wegener's granulomatosis. Rheumatology (Oxford) (2002) 1.41
The parallel Lack anaesthetic breathing system. Anaesthesia (1993) 1.41
Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet (1999) 1.36
Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE. Lupus (2013) 1.36
Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) (2005) 1.35
Phosphate permeases of Saccharomyces cerevisiae: structure, function and regulation. Biochim Biophys Acta (1999) 1.30
The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford) (2000) 1.25
Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus. Lupus (2003) 1.21
Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin. Leukemia (2007) 1.20
Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML. Leukemia (2007) 1.14
Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis (2003) 1.14
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia. Leukemia (2012) 1.14
An EGS4-ready tomographic computational model of a 14-year-old female torso for calculating organ doses from CT examinations. Phys Med Biol (1999) 1.09
Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19. J Clin Microbiol (1993) 1.07
Administration of chemotherapy with palliative intent in the last 30 days of life: the balance between palliation and chemotherapy. Intern Med J (2013) 1.03
Intracellular localization of an active green fluorescent protein-tagged Pho84 phosphate permease in Saccharomyces cerevisiae. FEBS Lett (1999) 1.01
Totally implantable vascular access in treatment of cystic fibrosis. Lancet (1986) 1.00
Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann Rheum Dis (2006) 1.00
The effects of intravenous clonidine on ventilation. Anaesthesia (1991) 0.99
Intracerebral arterial stenosis with neurological events associated with antiphospholipid syndrome. Rheumatology (Oxford) (2005) 0.99
Diagnostic x-ray spectra: a comparison of spectra generated by different computational methods with a measured spectrum. Med Phys (1998) 0.99
Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol (1993) 0.99
Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology (Oxford) (2003) 0.99
Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients. Br J Haematol (2001) 0.97
Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford) (2004) 0.96
Anti-tumor activity against multiple myeloma by combination of KW-2478, an Hsp90 inhibitor, with bortezomib. Blood Cancer J (2012) 0.95
Frequency of leukemic initiating cells does not depend on the xenotransplantation model used. Leukemia (2011) 0.94
Phosphate permeases of Saccharomyces cerevisiae. Biochim Biophys Acta (1998) 0.94
Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis. Clin Exp Immunol (1994) 0.93
Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study. Ann Rheum Dis (2003) 0.93
Effects of opioids and sedatives on survival in an Australian inpatient palliative care population. Intern Med J (2005) 0.92
Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome. Ann Rheum Dis (1992) 0.91
SNP discovery and genetic mapping of T-DNA insertional mutants in Fragaria vesca L. Theor Appl Genet (2010) 0.91
Mathematical analysis of antigen selection in somatically mutated immunoglobulin genes associated with autoimmunity. Lupus (2010) 0.89
Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis (2005) 0.89
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford) (2002) 0.88
Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures. Ann Rheum Dis (2004) 0.88
Anticardiolipin antibodies in a patient with Crohn's disease and thrombosis. Clin Exp Rheumatol (1992) 0.87
Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis: a preliminary study. Lupus (1991) 0.87
A 5-year clinical review of bond failure with a light-cured resin adhesive. Angle Orthod (1998) 0.86
Difficult asthma or Churg-Strauss syndrome? BMJ (1999) 0.86
Pre-oxygenation: the Hudson mask as an alternative technique. Anaesthesia (1992) 0.85
Anti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome. Ann Rheum Dis (2007) 0.85
Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis. Rheumatology (Oxford) (2008) 0.84
Medically assisted hydration for palliative care patients. Cochrane Database Syst Rev (2008) 0.84
The NIH pulse cyclophosphamide regime: the end of an era? Lupus (2004) 0.84
Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis. Lupus (2013) 0.84
A comparison of radiation dose measured in CT dosimetry phantoms with calculations using EGS4 and voxel-based computational models. Phys Med Biol (1997) 0.84
Mycophenolate mofetil treatment in resistant myositis. Rheumatology (Oxford) (2006) 0.83
Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy. Rheumatology (Oxford) (2005) 0.83
Laboratory evaluation of a compomer and a resin-modified glass ionomer cement for orthodontic bonding. Angle Orthod (1999) 0.83
Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD. Bone Marrow Transplant (2011) 0.82
Vasculitis, antiphospholipid antibodies, and renal artery stenosis. Ann Rheum Dis (2005) 0.82
Atherogenesis in rheumatology. Lupus (2006) 0.82
Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. Rheumatology (Oxford) (2004) 0.82
Renal artery stenosis: a new facet of the antiphospholipid (Hughes) syndrome. Lupus (2003) 0.82
Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning--evidence for a superior outcome using melphalan combined with total body irradiation. Br J Haematol (2005) 0.81
Coeliac artery stenosis and antiphospholipid (Hughes) syndrome/antiphospholipid anti-bodies. Clin Exp Rheumatol (2006) 0.81
An UK myeloma forum phase II study of thalidomide; long term follow-up and recommendations for treatment. Leuk Res (2003) 0.81
Regression of post-transplant Kaposi's sarcoma using sirolimus. Int J Clin Pract (2006) 0.80
Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. Rheumatology (Oxford) (2004) 0.79
Optimising testing for phospholipid antibodies. J Clin Pathol (2001) 0.79
Low-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet's disease. Clin Rheumatol (2006) 0.79
Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome. Rheumatology (Oxford) (2007) 0.78
Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants. J Lipid Res (1997) 0.78
Increased risk of vascular complications in Takayasu's arteritis patients with positive lupus anticoagulant. Scand J Rheumatol (2014) 0.77
A case of mistaken identity: subacute bacterial endocarditis associated with p-antineutrophil cytoplasmic antibody. BMJ Case Rep (2010) 0.77
United Kingdom myeloma forum position statement on the use of lenalidomide in multiple myeloma. Int J Lab Hematol (2008) 0.77
Syndrome X (angina pectoris with normal coronary arteries) and myocardial infarction in patients with anti-phospholipid (Hughes) syndrome. Lupus (2008) 0.77
Treatment of mesenteric angina with prolonged anticoagulation in a patient with antiphospholipid (Hughes) syndrome and coeliac artery stenosis. Ann Rheum Dis (2006) 0.77
Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies. Ann Rheum Dis (2005) 0.77
Prevalence of an abnormal ankle-brachial index in patients with antiphospholipid syndrome with pregnancy loss but without thrombosis: a controlled study. Ann Rheum Dis (2006) 0.77
Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients. Ann Rheum Dis (2007) 0.76
Paraproteins and monoclonal expansion of CD3+CD8+ CD56-CD57+ T lymphocytes in a patient with HIV infection. Br J Haematol (1999) 0.76
Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis. Ann Rheum Dis (2008) 0.76
Anti-D immunoglobulin treatment for thrombocytopenia associated with primary antibody deficiency. J Clin Pathol (2002) 0.76
The measurement of plasma catecholamine and lactate thresholds: a comparison of methods. Eur J Appl Physiol (2000) 0.76
Impaired neutrophil killing in a patient with defective degranulation of myeloperoxidase. J Clin Lab Immunol (1988) 0.76
The effect on dose to computed tomography phantoms of varying the theoretical x-ray spectrum: a comparison of four diagnostic x-ray spectrum calculating codes. Med Phys (1998) 0.76
Antiendothelial cell antibodies (AECA) in patients with uveoretinitis. Clin Rev Allergy Immunol (1997) 0.76
Hepatitis-associated aplastic anaemia treated successfully with antilymphocyte globulin. Clin Lab Haematol (2005) 0.76
Pyridoxine toxicity courtesy of your local health food store. Ann Rheum Dis (2006) 0.76
The point prevalence of an abnormal ankle-brachial index in antiphospholipid antibody negative patients with livedo reticularis: a controlled study. Ann Rheum Dis (2008) 0.76
Early and late reactions in contact sensitivity in the mouse. Int Arch Allergy Appl Immunol (1981) 0.75
Fever, haemoptysis and a mass in the heart. J R Soc Med (2007) 0.75
Increased cutaneous reactions to hydroxychloroquine (Plaquenil) possibly associated with formulation change: comment on the letter by Alarcón. Arthritis Rheum (2002) 0.75
Spontaneous pneumomediastinum in two stowaways. Br Med J (Clin Res Ed) (1986) 0.75
Introduction. Emerging infections: what have we learnt from SARS? Philos Trans R Soc Lond B Biol Sci (2004) 0.75
Rheumatology. Postgrad Med J (1991) 0.75
Dermatomyositis developing in a Duchenne muscular dystrophy carrier. Rheumatology (Oxford) (2004) 0.75
Antiendothelial cell antibodies in chronic urticaria. Clin Exp Rheumatol (1995) 0.75
Renal microinfarction in Behçet's disease. Rheumatology (Oxford) (2003) 0.75
Pancytopenia in ANCA associated vasculitis: response to immunosuppressive therapy. Clin Exp Rheumatol (2003) 0.75
MALToma and lupus. Lupus (2005) 0.75